AKT1 and colorectal carcinoma: It was observed that high levels of INHBA in tumor tissues were associated with poor prognosis of CRC patients, and metformin could significantly inhibit the mRNA and protein expression of INHBA and down-regulate TGF-β/PI3K/Akt signal transductions to achieve an inhibitory effect on the proliferation of CRC.